EV Biologics Revenue

In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%.

Revenue

9.47M

Revenue Growth

-70.48%

P/S Ratio

0.09

Revenue / Employee

n/a

Employees

n/a

Market Cap

840.53K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2017	9.47M	-32.45K	-0.34%
Jun 30, 2017	9.51M	-33.14M	-77.71%
Jun 30, 2016	42.64M	-3.59M	-7.76%
Jun 30, 2015	46.23M	1.77M	3.99%
Jun 30, 2014	44.46M	1.98M	4.65%
Jun 30, 2013	Pro	Pro	Pro
Jun 30, 2012	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Lipella Pharmaceuticals	389.78K
SQZ Biotechnologies Company	12.12M
Emmaus Life Sciences	11.89M
Scorpius Holdings	1.72M
Eastgate Biotech	137.64K
Halberd	6.94K
Evofem Biosciences	17.73M
International Stem Cell	9.39M

Revenue Rankings